These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35141150)

  • 1. Pan-Cancer Analyses Reveal Oncogenic Role and Prognostic Value of F-Box Only Protein 22.
    Chen S; Ma S; Yan J; Wang H; Ding B; Guo Z; Ma Y; Chen X; Wang Y
    Front Oncol; 2021; 11():790912. PubMed ID: 35141150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
    Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fbxo22 promotes cervical cancer progression via targeting p57
    Lin M; Zhang J; Bouamar H; Wang Z; Sun LZ; Zhu X
    Cell Death Dis; 2022 Sep; 13(9):805. PubMed ID: 36127346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBXO22 Accelerates Pancreatic Cancer Growth by Deactivation of the Hippo Pathway via Destabilizing LATS2.
    Ma J; Wu Y; Cheng S; Yang W; Zhong L; Li Q; Fang L
    Dig Dis Sci; 2023 May; 68(5):1913-1922. PubMed ID: 36515852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging role of FBXO22 in carcinogenesis.
    Cheng J; Lin M; Chu M; Gong L; Bi Y; Zhao Y
    Cell Death Discov; 2020; 6():66. PubMed ID: 32793396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FBXO22 inhibits proliferation and metastasis of cervical cancer cells by mediating ubiquitination-dependent degradation of GAK.
    Li S; Shi L; Wang Y; Zhang L; Chu S; Li M; Bai J; Zhu W
    Exp Cell Res; 2023 Sep; 430(1):113719. PubMed ID: 37442264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FBXO22, an epigenetic multiplayer coordinating senescence, hormone signaling, and metastasis.
    Johmura Y; Harris AS; Ohta T; Nakanishi M
    Cancer Sci; 2020 Aug; 111(8):2718-2725. PubMed ID: 32536008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FBXO22 mediates polyubiquitination and inactivation of LKB1 to promote lung cancer cell growth.
    Zhu XN; He P; Zhang L; Yang S; Zhang HL; Zhu D; Liu MD; Yu Y
    Cell Death Dis; 2019 Jun; 10(7):486. PubMed ID: 31217475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fbxo22 inhibits metastasis in triple-negative breast cancer through ubiquitin modification of KDM5A and regulation of H3K4me3 demethylation.
    Li S; He J; Liao X; He Y; Chen R; Chen J; Hu S; Sun J
    Cell Biol Toxicol; 2023 Aug; 39(4):1641-1655. PubMed ID: 36112263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression.
    Sun R; Xie HY; Qian JX; Huang YN; Yang F; Zhang FL; Shao ZM; Li DQ
    Cancer Res; 2018 Sep; 78(18):5274-5286. PubMed ID: 29945959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pan-cancer analysis revealing the role of LFNG, MFNG and RFNG in tumor prognosis and microenvironment.
    Gong X; Zheng C; Jia H; Liu Y; Yang R; Chen Z; Pan Y; Li X; Liu Y
    BMC Cancer; 2023 Nov; 23(1):1065. PubMed ID: 37932706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global identification of phospho-dependent SCF substrates reveals a FBXO22 phosphodegron and an ERK-FBXO22-BAG3 axis in tumorigenesis.
    Liu P; Cong X; Liao S; Jia X; Wang X; Dai W; Zhai L; Zhao L; Ji J; Ni D; Liu Z; Chen Y; Pan L; Liu W; Zhang J; Huang M; Liu B; Tan M
    Cell Death Differ; 2022 Jan; 29(1):1-13. PubMed ID: 34215846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCF
    Bai J; Wu K; Cao MH; Yang Y; Pan Y; Liu H; He Y; Itahana Y; Huang L; Zheng JN; Pan ZQ
    Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11754-11763. PubMed ID: 31138683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FBXO22 Promotes Growth and Metastasis and Inhibits Autophagy in Epithelial Ovarian Cancers
    Li M; Zhao X; Yong H; Shang B; Lou W; Wang Y; Bai J
    Front Pharmacol; 2021; 12():778698. PubMed ID: 34950036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of FBXO22 inhibits melanoma cell migration, invasion and angiogenesis via the HIF-1α/VEGF pathway.
    Zheng Y; Chen H; Zhao Y; Zhang X; Liu J; Pan Y; Bai J; Zhang H
    Invest New Drugs; 2020 Feb; 38(1):20-28. PubMed ID: 30887251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCF(FBXO22) regulates histone H3 lysine 9 and 36 methylation levels by targeting histone demethylase KDM4A for ubiquitin-mediated proteasomal degradation.
    Tan MK; Lim HJ; Harper JW
    Mol Cell Biol; 2011 Sep; 31(18):3687-99. PubMed ID: 21768309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression.
    Tian X; Dai S; Sun J; Jin G; Jiang S; Meng F; Li Y; Wu D; Jiang Y
    Oncotarget; 2015 Sep; 6(26):22767-75. PubMed ID: 26087183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F-Box Protein FBXO22 Mediates Polyubiquitination and Degradation of CD147 to Reverse Cisplatin Resistance of Tumor Cells.
    Wu B; Liu ZY; Cui J; Yang XM; Jing L; Zhou Y; Chen ZN; Jiang JL
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FBXO22 promotes glioblastoma malignant progression by mediating VHL ubiquitination and degradation.
    Shen Z; Dong T; Yong H; Deng C; Chen C; Chen X; Chen M; Chu S; Zheng J; Li Z; Bai J
    Cell Death Discov; 2024 Mar; 10(1):151. PubMed ID: 38519492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBXO22 protein is required for optimal synthesis of the N-methyl-D-aspartate (NMDA) receptor coagonist D-serine.
    Dikopoltsev E; Foltyn VN; Zehl M; Jensen ON; Mori H; Radzishevsky I; Wolosker H
    J Biol Chem; 2014 Dec; 289(49):33904-15. PubMed ID: 25336657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.